Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement ...

Magic Johnson is now worth an estimated $1.2 billion. His career earnings as a basketball player was $40 million. The magic? He says it comes from—of course—teaming up.

Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...

s disease-related psychosis and agitation Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which ...

U.S. stocks were rising across the board on Wednesday morning, buoyed by the advance in megacap technology names. Under the surface, however, there is furious paddling. The Dow Jones Industrial ...

Johnson & Johnson (NYSE: JNJ) stock is up 1.8% in the five days after the company announced its $14.6 billion acquisition of ...

Pharma giant Johnson & Johnson is buying Intra-Cellular Therapies, eying sales growth above analysts’ expectations through ...

(Tom Williams/CQ-Roll Call, Inc via Getty Images) Trump endorsed Johnson Monday and told partygoers at Mar-a-Lago on New Year’s Eve, “he’s the one that can win right now,” the Wall Street ...